ConductScience.org, home

Paper41283232

The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities.

George MY and 6 others. Hematol Rep, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities. Papers, record 41283232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41283232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Gut Microbiome Role in Multiple Myeloma: Emerging Insights and Therapeutic Opportunities.
PubMed
Journal
Hematol Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.51, provisional
iCite
Revised in PubMed
2025-11-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1George MYMina Yhttps://orcid.org/0000-0003-2887-9937
2Gamal NKNada K
3Mansour DEDaniel Ehttps://orcid.org/0000-0002-3435-3061
4Famurewa ACAdemola Chttps://orcid.org/0000-0002-8795-9964
5Bose DDebalinahttps://orcid.org/0009-0005-0350-3839
6Messiha PAPeter A
7Cerchione CClaudiohttps://orcid.org/0000-0002-9104-5436

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References112

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138239921Lachnospiraceae are emerging industrial biocatalysts and biotherapeutics.Front Bioeng Biotechnol2023https://conductscience.org/library/papers/38239921PubMed
228546562The interplay between host immune cells and gut microbiota in chronic inflammatory diseases.Exp Mol Med2017https://conductscience.org/library/papers/28546562PubMed
335892821The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/35892821PubMed
430257956Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.Sci Transl Med2018https://conductscience.org/library/papers/30257956PubMed
58040890Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.J Natl Cancer Inst1994https://conductscience.org/library/papers/8040890PubMed
615563667Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma.J Clin Pathol2004https://conductscience.org/library/papers/15563667PubMed
7162868Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats.Cancer Res1975https://conductscience.org/library/papers/162868PubMed
826160380MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.Science2015https://conductscience.org/library/papers/26160380PubMed
929567829The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.Cancer Discov2018https://conductscience.org/library/papers/29567829PubMed
1034072068CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.Cancers (Basel)2021https://conductscience.org/library/papers/34072068PubMed
1138283805An overview of multiple myeloma: A monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities.Saudi J Biol Sci2024https://conductscience.org/library/papers/38283805PubMed
1233369893Clinical effects and applications of the gut microbiome in hematologic malignancies.Cancer2021https://conductscience.org/library/papers/33369893PubMed
1339645617Canagliflozin differentially modulates carfilzomib-induced endoplasmic reticulum stress in multiple myeloma and endothelial cells.Arch Toxicol2025https://conductscience.org/library/papers/39645617PubMed
1423954158Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.Cell Host Microbe2013https://conductscience.org/library/papers/23954158PubMed
1527268090Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.Blood2016https://conductscience.org/library/papers/27268090PubMed
1621034972Intestinal dendritic cells.Adv Immunol2010https://conductscience.org/library/papers/21034972PubMed
1735211412Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment.Front Oncol2022https://conductscience.org/library/papers/35211412PubMed
1830941641T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.Arch Pharm Res2019https://conductscience.org/library/papers/30941641PubMed
1927117829Germ-free and Antibiotic-treated Mice are Highly Susceptible to Epithelial Injury in DSS Colitis.J Crohns Colitis2016https://conductscience.org/library/papers/27117829PubMed
2033167336Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability.Cancers (Basel)2020https://conductscience.org/library/papers/33167336PubMed

See all 112 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42329290Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats.Inflammopharmacology2026https://conductscience.org/library/papers/42329290PubMed
42068673Genetic architecture of multiple myeloma: From somatic alterations to germline susceptibility and clinical implications.Transl Oncol2026https://conductscience.org/library/papers/42068673PubMed
42068402Targeting the immunological synapse in multiple myeloma.Discov Oncol2026https://conductscience.org/library/papers/42068402PubMed
41977190Oxidative Stress in Multiple Myeloma: Pathogenic Mechanisms, Biomarkers, and Redox-Targeted Therapeutic Strategies.Int J Mol Sci2026https://conductscience.org/library/papers/41977190PubMed
41562912From Glucose Transport to Microbial Modulation: The Impact of Sodium Glucose Co-Transporter-2 Inhibitors on the Gut Microbiota.Med Sci (Basel)2026https://conductscience.org/library/papers/41562912PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41283232

GET https://conductscience.org/api/papers/v1/41283232/references?page=2